DiaMedica Therapeutics Files 8-K
Ticker: DMAC · Form: 8-K · Filed: May 15, 2025 · CIK: 1401040
| Field | Detail |
|---|---|
| Company | Diamedica Therapeutics Inc. (DMAC) |
| Form Type | 8-K |
| Filed Date | May 15, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-action, financials
TL;DR
DiaMedica filed an 8-K on May 15th, reporting on shareholder votes and financials.
AI Summary
DiaMedica Therapeutics Inc. filed an 8-K on May 15, 2025, reporting on matters submitted to a vote of security holders and financial statements. The company, formerly known as DiaMedica Inc., is incorporated in British Columbia, Canada, with principal executive offices in Minneapolis, Minnesota.
Why It Matters
This filing indicates corporate actions and financial reporting updates for DiaMedica Therapeutics Inc., which could impact investors' understanding of the company's status.
Risk Assessment
Risk Level: low — This is a routine corporate filing reporting on standard business matters and financial statements.
Key Players & Entities
- DiaMedica Therapeutics Inc. (company) — Registrant
- May 15, 2025 (date) — Date of earliest event reported
- DiaMedica Inc. (company) — Former company name
- 301 Carlson Parkway, Suite 210 Minneapolis, Minnesota 55305 (address) — Principal executive offices
FAQ
What is the primary purpose of this 8-K filing?
The primary purpose of this 8-K filing is to report on matters submitted to a vote of security holders and to provide financial statements and exhibits.
When was the earliest event reported in this filing?
The earliest event reported in this filing was on May 15, 2025.
What is the current name of the registrant?
The current name of the registrant is DiaMedica Therapeutics Inc.
What was the former name of the company?
The former name of the company was DiaMedica Inc.
Where are DiaMedica Therapeutics Inc.'s principal executive offices located?
DiaMedica Therapeutics Inc.'s principal executive offices are located at 301 Carlson Parkway, Suite 210, Minneapolis, Minnesota 55305.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on May 15, 2025 regarding DiaMedica Therapeutics Inc. (DMAC).